The DOI matches its Crossref record; 75 of the 76 references it cites were found in a registry or an index.
Drug treatments in Alzheimer’s disease
Open accessAbstract
Despite the significant public health issue that it poses, only five medical treatments have been approved for Alzheimer's disease (AD) and these act to control symptoms rather than alter the course of the disease. Studies of potential disease-modifying therapy have generally been undertaken in patients with clinically detectable disease, yet evidence suggests that the pathological changes associated with AD begin several years before this. It is possible that pharmacological therapy may be beneficial in this pre-clinical stage before the neurodegenerative process is established. Techniques providing earlier diagnosis, such as cerebrospinal fluid biomarkers and amyloid positron emission tomography neuroimaging, are key to testing this theory in clinical trials. Recent results from trials of agents such as aducanumab are encouraging but must also be interpreted with caution. Such medicines could potentially delay the onset of dementia and would therefore markedly reduce its prevalence. However, we currently remain a good distance away from clinically available disease-modifying therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Current treatments for AD, including cholinesterase inhibitors and memantine, offer limited symptom relief, especially in the early to moderate stages, but do not halt disease progression or address the underlying neurodegeneration.”
From Cholinesterase Inhibitors from Plants and Their Potential in Alzheimer’s Treatment: Systematic Review (2025) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Four drugs (donepezil, memantine, galantamine, rivastigmine) are approved on the market and belong to two families: anticholinesterase inhibitors and anti-glutaminergics.”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [155]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60461-5 · Cited by 3,689
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345
Bloom (2014) · doi:10.1001/jamaneurol.2013.5847 · Cited by 2,194
Jack, C. R., Albert, M. S., Knopman, D. S., McKhann, G. M., Sperling, R. A., Carrillo, M. C., Thies, B., & Phelps, C. H. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.004 · Cited by 2,042
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960
Research works printed but not linked: 1
- Mosconi, 2010, Pre-clinical detection of Alzheimer’s disease using FDG-PET, with or without amyloid imaging, J Alzheimers Dis, 20, 843, 10.3233/JAD-2010-091504 · DOI
Cited by
Sorted by citations
Items 401–500 of 576
Nanoparticles in the Treatment of Alzheimer’s Disease with Magnetic Resonance
Zhang, Y., Mao, W., Feng, M., Zhu, N., Yi, W., Fu, H., Guan, H., Nie, T., Zhu, M., & Li, Y. (2021) · Science of Advanced Materials · doi:10.1166/sam.2021.4041 · Cited by 3
Automatic Classification of Dementia Using Text and Speech Data
Han, H. J., Suhas, B. N., Qiu, L., & Abdullah, S. (2022) · Studies in computational intelligence · doi:10.1007/978-3-031-14771-5_29 · Cited by 3
Amisulpride Decreases Tau Protein Hyperphosphorylation in the Brain of OXYS Rats
Molobekova, C. A., Kondaurova, E. M., Ilchibaeva, T. V., Rodnyy, A. Y., Stefanova, N. A., Kolosova, N. G., & Naumenko, V. S. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230828144651 · Cited by 3
Neuroprotective properties of taurine
Cieślak, M., Karmańska, A., Kaźmierczak-Barańska, J., Korycka, M., & Karwowski, B. T. (2024) · Farmacja Polska · doi:10.32383/farmpol/181132 · Cited by 2
Cordia dichotoma G. Forst fruit prophylactic against Alzheimer's risk factors: in vitro study
Ibrahim, F. M., Ibrahim, A. Y., Amer, H. M., Ramadan, M. F., & Mohammed, R. S. (2024) · RENDICONTI LINCEI · doi:10.1007/s12210-024-01283-4 · Cited by 2
Zhao, Y., Ge, Y., Zhang, Z., Tan, C., Lu, Y., Guo, X., Tian, Y., Feng, X., Wu, Y., Li, S., et al. (2025) · Geriatric Nursing · doi:10.1016/j.gerinurse.2025.03.038 · Cited by 2
Yang, H., You, X., Yue, C., Yu, X., Yue, X., Zheng, X., Yan, X., Li, J., Bi, J., Zhang, L., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251390553 · Cited by 3
Rathod, S., & Agrawal, Y. O. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70317 · Cited by 2
Gentry, E., Islam, M. T., Xue, H., Cao, K., & Nemes, P. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.101490 · Cited by 2
Manoharan, S. D., Usman, A. S., Hamid, H. A., Nassir, C. M. N. C. M., Cheema, M. S., Ramli, M. D. C., Moklas, M. A. M., & Mehat, M. Z. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04702-0 · Cited by 2
Valenzuela-Hormazábal, P., Valero-Rojas, J., Martínez‐González, L., Ramos-Inza, S., Oviedo-Pino, V., González-Ortega, C., Hernando, G., López, J. J., Scorza, C., Echeverry, C., et al. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c02202 · Cited by 2
Peng, T., Zhang, Z., Ding, N., & Zhang, J. (2026) · Neural Plasticity · doi:10.1155/np/6718671 · Cited by 2
Leuci, R., Paparella, M., Cerini, M., Simić, S., Chaves, S., Carrieri, A., Tortorella, P., Loiodice, F., Laghezza, A., Santos, M. A., et al. (2026) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2026.118760 · Cited by 2
Liu, X., & Wang, Y. (2022) · Letters in Drug Design & Discovery · doi:10.2174/1570180819666220619125742 · Cited by 2
Han, R., Wang, M., Wang, L., Zhang, Y., Li, X., Hou, Y., Jing, Y., & Pan, X. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/3390034 · Cited by 2
Bhargava, V. P., Netam, A. K., Singh, R., & Sharma, P. (2023) · Toxicology International · doi:10.18311/ti/2023/v30i1/30863 · Cited by 2
Single-cell RNA sequencing analysis and Alzheimer's disease: a bibliometric analysis.
Soreq, L., & Mohamed, W. M. Y. (2023) · PubMed Central · Cited by 2
ALZHEIMER HASTALIĞI, RİSK FAKTÖRLERİ VE TEDAVİ
Yıldırım, N., & Eke, B. C. (2024) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.33483/jfpau.1441827 · Cited by 4
Han, L., Chen, W., Zong, Y., Zhao, Y., Li, J., He, Z., & Du, R. (2024) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2024.28.4.361 · Cited by 2
Mojzych, I., Zawadzka, A. M., Andrzejewski, K., Jampolska, M., Bednáriková, Z., Gančár, M., Gažová, Z., Mazur, M., & Kaczyńska, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810072 · Cited by 2
Qiao, N., & Shao, H. (2024) · Computer Methods in Biomechanics & Biomedical Engineering · doi:10.1080/10255842.2024.2399029 · Cited by 2
Camilo, C. J., Leite, D. O. D., de Carvalho, N. K. G., Castro, J. W. G., de Menezes, J. E. S. A., dos Santos, H. S., Silva, J. P. R. E., Alves, D. R., de Morais, S. M., Rodrigues, F. F. G., et al. (2024) · Plants · doi:10.3390/plants13213034 · Cited by 2
Alexandre-Silva, V., Soares‐Silva, B., Pereira, G. C., Custódio‐Silva, A. C., Carvalhinho-Lopes, P. S., Taliano, L. O., Lambertucci, R. H., Duarte, M. C., Araújo, A. A. D. S., Quintans‐Júnior, L. J., et al. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01484-8 · Cited by 2
Akinpelu, L. A., Adebayo, M. A., Aiyelero, O. M., Eniaiyewu, O. I., Bobra, R. T., & Anyacho, S. O. (2024) · Nigerian Journal of Pharmacy · doi:10.51412/psnnjp.2024.31 · Cited by 2
Jung, Y. H., Kim, J. P., Kim, H. J., Jang, H., Han, H. J., Koh, Y. H., Na, D. L., Suh, Y., Huh, G. Y., Won, J., et al. (2025) · Journal of Clinical Neurology · doi:10.3988/jcn.2024.0517 · Cited by 2
Delivoria, D. C., & Σκρέτας, Γ. (2020) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-0716-0720-6_13 · Cited by 2
Henry, V., Moszer, I., Dameron, O., Xicota, L., Dubois, B., Potier, M., Hofmann‐Apitius, M., & Olivier Colliot, A. (2021) · Database · doi:10.1093/database/baab004 · Cited by 4
Alzheimer’s Disease: An Insightful Review on the Future Trends of the Effective Therapeutics
Hashmi, A., Srivastava, V., Kalam, S. A., & Mishra, D. K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102762 · Cited by 2
Rumo a uma nova era no diagnóstico e tratamento da doença de Alzheimer
Ferrari‐Souza, J. P., & Schilling, L. P. (2023) · PAJAR - Pan-American Journal of Aging Research · doi:10.15448/2357-9641.2023.1.44542 · Cited by 2
Nanomicelles of taurine inhibit the fibrillation and toxicity of amyloid β1-42 peptide
Gomes-da-Silva, N. C., Soares, M. A. G., Ricci‐Júnior, E., Amorim, M. D. S. D. N., Alencar, L. M. R., Bhattarai, P., Zhu, L., Follmer, C., & Santos‐Oliveira, R. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104721 · Cited by 3
Wiklund, L., Sharma, A., Muresanu, D. F., Zhang, Z., Li, C., Tian, Z. R., Buzoianu, A. D., Lafuente, J. V., Nozari, A., Feng, L., et al. (2023) · Advances in neurobiology · doi:10.1007/978-3-031-32997-5_9 · Cited by 2
ElNagar, A. S., Mohyeldin, M. M., Mostafa, N. M., Ibrahim, S. S. A., Batiha, G. E., Mahmoud, M. H., Hriţcu, L., & Eldahshan, O. A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115382 · Cited by 2
Therapeutic approaches in proteinopathies
Nabi‐Afjadi, M., Dabirmanesh, B., & Uversky, V. N. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.03.008 · Cited by 2
(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg006 · Cited by 2
Wang, D., Ling, Y., Harris, K., Schulz, P. E., Jiang, X., & Kim, Y. (2023) · medRxiv · doi:10.1101/2023.10.27.23297685 · Cited by 3
Pharmacological and Neuroprotective Natural Products in the Treatment of Alzheimer’s Disease
Prashanthi, A. M., & Lakshmi, V. N. (2021) · International Journal of Science and Healthcare Research · doi:10.52403/ijshr.20210762 · Cited by 1
Anas, Y., Susidarti, R. A., Yuniarti, N., & Martien, R. (2022) · INDONESIAN JOURNAL OF PHARMACY · doi:10.22146/ijp.4432 · Cited by 1
Functional and molecular insights of hydrogen sulfide in the major central nervous system disorders
GuiJuan, Z. H. O. U., & Tang, X. (2023) · Scientia Sinica Vitae · doi:10.1360/ssv-2023-0093 · Cited by 1
Zakharov, V. V., & Koberskaya, N. N. (2024) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202412409134 · Cited by 1
Lin, C., Huang, J.-H., Lin, P.-H., Chen, T.-B., Wang, L.-M., Huang, Y., & Chen, K.-L. (2024) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2024.137134 · Cited by 2
The Microbial and Metabolic Link Between Gut and Brain
Salamalek, R., Shareef, Y., Abdulridha, F., & Soliman, S. S. M. (2025) · Springer eBooks · doi:10.1007/978-981-96-1305-2_17 · Cited by 1
Saffron’s promise: a systematic review of its role in Alzheimer's treatment
Norouzi, A., Jabraeilipour, A., Doustar, N., Sahrai, H., Saberivand, M., Mosaddeghi-Heris, R., Shahabifard, H., Talebi, M., Sanaie, S., & Naseri, A. (2025) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-025-00950-z · Cited by 1
Neuroprotective Potential of Thyme Essential Oil against Beta-Amyloid Toxicity in SH-SY5Y Cells
Shin, S. W., & Park, G. H. (2025) · Gyemyeong uidae haksulji · doi:10.46308/kmj.2025.00059 · Cited by 1
Tyagi, S., Kumar, J., & Kumar, S. (2025) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2025.2580488 · Cited by 1
Bachhav, S. S., Florian, H., Boiser, J. C., Wang, Y., Shiller, D., Graab, U., Lynch, S. Y., Graff, O. X., & Xiong, H. (2026) · Clinical and Translational Science · doi:10.1111/cts.70419 · Cited by 1
Cao, J., Song, J., Yin, Z., & Tang, Z. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70289 · Cited by 1
Wang, B., Cheng, K., Chen, Z., Chen, Y., Wang, Z., & Ni, J. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111837 · Cited by 1
Chou, P., Chien, C., Huang, L., & Yang, Y. (2026) · Dialogues in Clinical Neuroscience · doi:10.1080/19585969.2026.2658530 · Cited by 1
Hossain, M. M., Adhikari, J., & Shibly, A. Z. (2026) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2026.100774 · Cited by 1
Inhibition of miR-25-3p Alleviates Neuroinflammation in Alzheimer's Disease By Targeting ADAM10
Chen, P., Qiang, X., Zhao, Z., Wang, W. J., Zhen, H., & Liu, Y. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06042-0 · Cited by 1
Huo, C.-L., Yu, T., Pei, C.-Y., Liu, L., Zhang, Y., & Zhang, Y.-L. (2021) · Macromolecular Research · doi:10.1007/s13233-021-9046-z · Cited by 1
Neurodegenerative diseases and their related treatment
Xin, Z. (2021) · E3S Web of Conferences · doi:10.1051/e3sconf/202127103020 · Cited by 1
Nanomedicines and phytochemicals targeting Alzheimer’s disease
Das, B. B., Patel, P., Nandi, A., & Verma, S. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85666-9.00001-2 · Cited by 1
Does food have anything to do with Memory and Intelligence? A Review on Alzheimer's disease Fighting
Abushwereb, H. S. (2022) · EAS Journal of Pharmacy and Pharmacology · doi:10.36349/easjpp.2022.v04i02.003 · Cited by 1
Alzheimer’s Disease: Molecular Biology, Pathophysiology and Biomarkers
Mishra, Y., Singh, S., & Yadav, N. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815040913122010008 · Cited by 1
Associação entre os aspectos genéticos e imunológicos na patogênese do Alzheimer
Rodrigues, J. M., & Soares, L. S. (2022) · Revista Neurociências · doi:10.34024/rnc.2022.v30.14098 · Cited by 1
Guo, Z., Gao, B., Fan, M., Chen, L., Zhang, C., Liang, X., Su, W., & Xie, Y. (2023) · Molecules · doi:10.3390/molecules28052377 · Cited by 1
Natural Herbs Polishing Memory: Neuroprotection against Alzheimer's Disease
Thakkur, M., Dilnashin, H., & Keshri, P. K. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815040197123010017 · Cited by 1
Neuroprotective Effects of Gypenosides and Their Underlying Mechanisms
Zhou, C., Chen, J., & Wang, X. (2023) · Neurochemical Journal · doi:10.1134/s1819712423010208 · Cited by 1
Jindal, D., Pancham, P., Mani, S., Rachana, R., Haider, S., & Singh, M. (2023) · Lecture notes in mechanical engineering · doi:10.1007/978-981-99-3386-0_17 · Cited by 1
Satoh, K., Sato‐Ueshima, M., Kagami‐Katsuyama, H., Nakamura, M., Ogata, A., Maeda‐Yamamoto, M., & Nishihira, J. (2024) · Journal of Biotechnology and Biomedicine · doi:10.26502/jbb.2642-91280125 · Cited by 1
Avliyakulyeva, A. M., Kindyakova, E., Kuzmina, S. V., Gorina, Y. V., & Lopatina, O. L. (2024) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2024-1-105-115 · Cited by 2
Update on the pharmacological management of neurodegenerative diseases: Alzheimer’s disease
Flepisi, B. T., Hanser, S., & Balmith, M. (2024) · SA pharmaceutical journal. · doi:10.36303/sapj.0492 · Cited by 1
Khan, S. A., Qamar, Z., Rohilla, A., Singh, P. P., Parvez, S., Baboota, S., & Ali, J. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128348877241202053633 · Cited by 1
New Luminescent Cd(II) Coordination Polymer and Its Protective Activity on Alzheimer’s Disease
Hong, C., & Li, Y. (2022) · Science of Advanced Materials · doi:10.1166/sam.2022.4229 · Cited by 1
The Effects of Alzheimer’s Disease: Gender, Race, & Ethnicity
Rodriguez, K. A., Aleman, S., Rodriguez, H. E., Alvarez, A., Garza-Palacios, J. S., Trevino, M., Castro, G., Royal, N., & Ortiz, G. (2022) · DHR Proceedings · doi:10.47488/dhrp.v2is2.48 · Cited by 1
Perspectives of Stem Cell Therapy: A Promising Therapeutic for Cancer Model and Alzheimer’s Disease
Jeyachandran, S., Ganesan, G., Sangeetha, R., Paramasivan, V., Subbaraj, G. K., & Kulanthaivel, L. (2023) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-3824-5_32 · Cited by 1
Wang, F., Xu, C., Chen, W.-H., Duan, S., Xu, S., Dai, J., & Wang, Q. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3797592 · Cited by 2
Agnollitto, M. I. S. S. (2021) · doi:10.11606/t.17.2021.tde-07022022-150515 · Cited by 1
EVALUATING NATURAL PRODUCT LIBRARIES WITH EMPHASIS ON IN VITRO PERMEABILITY WORKFLOWS
Kirk, R. D. (2021) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-kirk-riley-2021 · Cited by 1
Application of Nanophytomedicine for the Treatment of Central Nervous System Disorders
Rarokar, N. R., Gurav, N. S., & Gurav, S. S. (2023) · Wiley eBooks · doi:10.1002/9781119794127.ch18 · Cited by 1
Computational Attitudes to Drug Discovery in Alzheimer's Disease
Maheshwari, S., Singh, A., Verma, A., Akhtar, J., Prajapati, J. B., Singh, S. K., & Prajapati, B. G. (2025) · doi:10.1002/9781394242474.ch11 · Cited by 1
INVESTIGATING NAT PRODUCTS & PHARMACEUTICALS TARGETING INFLAMMATION IN NEURODEGENERATIVE DISEASES
Johnson, S. L. (2020) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-johnson-shelby-2020
Alzheimer’s disease pathogenesis and risk factors
Gerulytė, A., & Strumylaitė, L. (2019) · Neurologijos seminarai · doi:10.29014/ns.2019.25
Gbadamosi, I., & Omotoso, G. O. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.09.195495
Arias, J. A., Cadarso-Suárez, C., & Aguiar, P. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2102.02908
Yu, L., Pei, S., Yuan, K., Zhang, J., Zhao, J., & Chai, S. (2021) · Research Square · doi:10.21203/rs.3.rs-250110/v1
Fang, M., Zeng, P. H., Chen, J., Zhao, H., Wang, H., & Guo, J. (2021) · International Conference on Biological Information and Biomedical Engineering (BIBE) · doi:10.1145/3469678.3469695
Effective Use of Empirical Data for Virtual Screening against APJR GPCR Receptor
Manoliu, L. C. E., Martin, E. C., Milac, A. L., & Spiridon, L. N. (2021) · Molecules · doi:10.3390/molecules26164894
Zhang, Y.-D., Liu, Z.-J., Wang, H.-P., & Zhang, H.-Y. (2021) · Inorganic and Nano-Metal Chemistry · doi:10.1080/24701556.2021.1966457
RetractedPang, J., Pang, J., & Qiu, Z.-K. (2021) · Research Square · doi:10.21203/rs.3.rs-793765/v1
Tolentino, R., McMahon, A., & Coward, E. (2021) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.309
Emerging evolution trends of application of natural products in Alzheimer’s disease
Wang, X., Li, X., Zhang, L., Guo, R., Sun, X., Sun, R. X., Li, Z., Wang, L., Yue, C., & Lyu, Y. (2021) · Journal of Computational Methods in Sciences and Engineering · doi:10.3233/jcm-215870
Liu, W., Yang, Y., Jin, Y., Song, C., Ye, X., & Zhu, W. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3996123
Biomedical and Potential Therapeutic Aspects of Lithium Carbonate Use
Sorokina, Y. А., Алексеевна, М. А., Pakhomova, Y. M., & Занозин, А. В. (2022) · Psikhiatriya · doi:10.30629/2618-6667-2022-20-2-109-116
Alzheimer’s Disease: Newly Proposed Pathologies and Predicted Therapies
Liu, H. (2022) · International Conference on Biotechnology, Life Science and Medical Engineering (BLSME) · doi:10.23977/blsme.2022023
Perspectives of Stem Cell Therapy: A Promising Therapeutic for Cancer Model and Alzheimer’s Disease
Jeyachandran, S., Ganesan, G., Sangeetha, R., Paramasivan, V., Subbaraj, G. K., & Kulanthaivel, L. (2022) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-1282-5_32-1
Polypharmacology in Clinical Applications: Neurological Polypharmacology
Wang, Z., & Yang, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-04998-9_6
Progress in the Detection of Cerebrospinal Fluid by Raman Spectroscopy
Zeng, T., Song, Y., Bian, H., Lin, T., Liu, Y., Deng, S., Liao, J., Mao, Z., & Chen, S. (2022) · Current Nanoscience · doi:10.2174/1573413718666220803141856
Gene-expression control in early and late-onset dementia
Zhou, J. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9465
Cannabidiol and Trazodone Ameliorate Neuronal Proteotoxicity in C. elegansPreprint
Gilberto, V. S., McGrath, S., Alsulami, A., Vidrio-Aguirre, A., & Moreno, J. A. (2022) · Research Square · doi:10.21203/rs.3.rs-2351138/v1
Grain-sized moxibustion inhibits the progression of Alzheimer disease in 5XFAD transgenic mice
Yu, J., Gong, X., Chu, J., Zhang, Y., Fan, Z., Li, S., & Bao, Y. (2022) · Journal of Acupuncture and Tuina Science · doi:10.1007/s11726-022-1342-4
Brain RAS in CNS Diseases: Beneficial Effects of Small Molecule Agonists and Inhibitors
Wright, J. W., & Harding, J. W. (2022) · Annals of Hematology & Oncology · doi:10.26420/annhematoloncol.2022.1388
Nameni, F., & Firoozmand, F. (2022) · Jorjani Biomedicine Journal · doi:10.52547/jorjanibiomedj.10.2.36
Iwasa, K., Yagishita, S., Yagishita-Kyo, N., Yamagishi, A., Yamamoto, S., Yamashina, K., Haruta, C., Asai, M., Maruyama, K., Shimizu, K., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2581351/v1
A Review of the pharmacological treatments of Alzheimer’s disease (AD)
Jiang, D. F., & Xiao, Y. (2022) · Journal of Student Research · doi:10.47611/jsrhs.v11i3.3475
Xia, X., Xiao, J., Li, Q., Xiong, L., Li, S., & Guo, C. (2023) · Research Square · doi:10.21203/rs.3.rs-2942361/v1
Zheng, X.-Y., Zhang, H.-C., Wei, Z.-W., Lv, Y., Jin, F., Zhu, J., & Ruan, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-3517043/v1
Mechanism and treatment of Alzheimer’s disease
Gu, Z., Tie, Z., & Ruan, H. (2023) · Theoretical and Natural Science · doi:10.54254/2753-8818/21/20230865
Manjunath, K., Kaur, A., Paramesh, D. B., & Murthy, S. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815136142123010014
Metadata
- Authors
- Briggs, R., Kennelly, S. P., & O’Neill, D.
- Affiliations
- Tallaght University Hospital (IE)
- Venue
- Clinical Medicine
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 16
- Issue
- 3
- Pages
- 247-253
- ISSN
- 1470-2118 (ISSN-L)
- PMC
- PMC5922703
- OpenAlex
- W2415242066
- Cited by
- 571
- References
- 76
- Citations by year
- 2026: 37 · 2025: 67 · 2024: 97 · 2023: 79 · 2022: 106 · 2021: 95 · 2020: 55 · 2019: 18 · 2018: 5 · 2017: 9 · 2016: 2
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Clinical Medicine (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, pharmacotherapy, disease-modifying therapy, symptomatic treatment, preclinical Alzheimer's disease, cerebrospinal fluid biomarkers, amyloid PET, aducanumab, early diagnosis, dementia prevention
- MeSH terms
- Alzheimer Disease, Amyloid, Cholinesterase Inhibitors, Humans, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
